Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
LenioBio is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Germany
Founded:2019
Employees:2,646
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval P2E107
FDA · #APR-OS3QTS5V · 2019-08-01
Drug Approval BLSJEV
Health Canada · #APR-XHCX6KBJ · 2022-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-AZGRNR11
Issued: 2020-07-16
Expires: 2025-09-01
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-LZJCGXL7
Issued: 2020-06-28
Expires: 2025-02-09
WHO GMP
World Health Organization
Cert #: CERT-25NY2F64
Issued: 2020-04-24
Expires: 2025-11-06
Loading CDMO intelligence...
Key facts about LenioBio
- LenioBio is headquartered in Germany.
- LenioBio was founded in 2019.
- LenioBio has 2,646 employees.
- LenioBio's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like LenioBio
Directory pages this company appears in, each with the full list of matching manufacturers.